HerbParlor
Nettle (Urtica dioica L.)Emerging evidence

Nettle

Urtica dioica L.

Overview

At a glance

Nettle (Urtica dioica L.) is a Urticaceae botanical represented by leaf/herb and root preparations. Human research is preparation- and outcome-dependent, including root-focused BPH/LUTS studies and heterogeneous metabolic or glycemic research.

Key takeaway

Nettle is not one uniform intervention. Leaf/herb and root are distinct materials, and tea, powder, capsule, extract and glycerite products may differ in composition and evidence relevance. Some studies report BPH/LUTS or metabolic findings, but the evidence does not establish nettle as a treatment for BPH, diabetes, inflammation or other diseases.

Common uses studied

Leaf/herb tea and powder preparationsLeaf and herb capsule productsRoot extract and root capsule researchBPH and lower urinary tract symptom researchMetabolic and glycemic research

Start here

What are you trying to figure out?

Pick the question closest to yours. Each card jumps to the relevant part of this profile or an existing HerbParlor tool — no sponsored rankings, no hidden ordering.

Understand the herbExplore the evidenceUnderstand formsCheck safetyEvaluate a supplementCompare options

Identity

What is this herb?

Family

Urticaceae

Species

Urtica dioica L.

Common names

NettleStinging nettle

Plant parts used

Leaf / herbRoot

Geographic context

Urtica dioica L. is a widely distributed Urticaceae species. Botanical identity and the plant part used should be confirmed from the product or source record rather than inferred from the common name alone.

Identification notes

Nettle products should identify Urtica dioica L. where possible and should distinguish leaf/herb material from root. Leaf/herb and root are not interchangeable interventions, and a product labelled only “nettle” does not by itself establish which plant part or preparation is present.

Background

Traditional context

Traditions

European and Western herbal-medicine contexts

Historical uses

Historical use of nettle leaf/herb preparationsHistorical use of nettle root preparations

Traditional use is historical and cultural context, not proof of efficacy. Conclusions about a product should be based on the specific Urtica dioica plant part, preparation, outcome and human evidence studied.

Preparations

Forms & preparations

Forms

Leaf/herb teaLeaf/herb powderLeaf or herb capsuleRoot extractLeaf or root extractGlycerite

Preparation methods

Infusion or tea made from leaf/herb materialDried leaf/herb powderEncapsulated leaf, herb or root materialLiquid or dry extract where explicitly disclosedGlycerite where explicitly disclosed

What changes between forms

  • Leaf/herb and root are distinct plant parts and should not be treated as interchangeable preparations.
  • Root preparations used in BPH/LUTS research should not be generalized to leaf tea, leaf powder or leaf capsules.
  • Tea, powder, capsule, extract and glycerite products may differ in plant part, extraction method, composition and amount.
  • A named extract or research preparation is not automatically equivalent to every commercial nettle product.
  • Combination products should not automatically be treated as evidence for nettle alone.

Human studies have used different nettle plant parts and preparations. The relevant intervention is the identified plant part and preparation, not the word “nettle” alone.

Research

Research Explorer

Each question summarizes what human research has examined, how it was studied, and the main limitations — not a treatment recommendation.

What does human research show about nettle root and BPH or lower urinary tract symptoms?

Population

Men represented in randomized trials and reviews of nettle root preparations for benign prostatic hyperplasia or related lower urinary tract symptoms.

Intervention

Nettle root preparations as described in the specific studies, with plant part and formulation interpreted at study level.

Comparator

Placebo, control or comparator treatment where used.

Outcomes studied

Lower urinary tract symptomsUrinary measuresProstate-related outcomesAdverse events

Evidence assessment

Some studies report BPH or lower urinary tract symptom findings for specific nettle root preparations. The evidence is heterogeneous and preparation-dependent, and these findings do not establish nettle root as an established BPH treatment. Root evidence must not be generalized to leaf tea, leaf powder, leaf capsules or other nettle products.

Limitations

  • Variation in root preparations and formulations
  • Differences in populations, comparators and outcome measures
  • Limitations in study size, duration or methodological quality
  • Findings should not be generalized to leaf/herb preparations

Sources

  • Nettle root and benign prostatic hyperplasia / lower urinary tract symptoms — randomized controlled trial / PubMed
  • Nettle root and benign prostatic hyperplasia / lower urinary tract symptoms — randomized controlled trial / PubMed
  • Nettle root preparations — evidence review / PubMed

What does human research show about nettle and metabolic or glycemic outcomes?

Population

People represented in human clinical research and evidence synthesis concerning nettle preparations and metabolic or glycemic outcomes.

Intervention

Nettle preparations described in the relevant studies; the plant part and formulation may vary and must be checked in the source.

Comparator

Placebo, usual care or comparator interventions where used.

Outcomes studied

Blood glucose measuresMetabolic markersOther reported clinical outcomesAdverse events

Evidence assessment

Some human studies and a meta-analysis report metabolic or glycemic findings for particular nettle preparations. The evidence is heterogeneous, and a change in a laboratory measure is not the same as established treatment of diabetes or a related disease. The findings do not establish nettle as a diabetes treatment and should not be generalized across leaf/herb and root products.

Limitations

  • Heterogeneous preparations, populations and outcome measures
  • Laboratory or surrogate outcomes may not represent patient-important benefit
  • Uncertainty about preparation-specific clinical relevance
  • Insufficient basis for a dosage recommendation

Sources

Why must leaf/herb and root evidence be interpreted separately?

Population

People comparing commercial nettle leaf/herb products with nettle root products and the preparations used in human research.

Intervention

Leaf/herb and root preparations including tea, powder, capsules, extracts and glycerites where described.

Comparator

Not applicable.

Outcomes studied

Plant-part identityPreparation identityEvidence interpretability

Evidence assessment

Leaf/herb and root are distinct preparations. A root study, including a BPH/LUTS study, does not validate a leaf tea or leaf powder. Likewise, evidence for one extract or glycerite does not automatically establish the effects of another nettle preparation.

Limitations

  • Commercial labels may omit plant-part or extract details
  • Studies do not use one uniform nettle intervention
  • Plant-part and preparation differences limit direct comparison

Sources

How strong and consistent is the overall human evidence?

Population

People represented across the available Urtica dioica human clinical literature.

Intervention

Nettle leaf/herb and root preparations studied in humans.

Comparator

Varies by study and review.

Outcomes studied

BPH/LUTS outcomesMetabolic and glycemic outcomesSafety outcomesEvidence interpretability

Evidence assessment

The human evidence is outcome- and preparation-dependent. Some studies report BPH/LUTS and metabolic findings, but evidence is heterogeneous and does not establish nettle as a proven treatment for BPH, diabetes, inflammation or other diseases. The evidence should be read at the level of the identified plant part, preparation and outcome.

Limitations

  • Limited ability to generalize between leaf/herb and root
  • Variation in extracts, products and study methods
  • Uncertainty about clinical importance and long-term safety
  • Insufficient evidence for broad disease or inflammation claims

Sources

  • Urtica dioica L. — Plants of the World Online
  • Nettle root and benign prostatic hyperplasia / lower urinary tract symptoms — randomized controlled trial / PubMed
  • Nettle root and benign prostatic hyperplasia / lower urinary tract symptoms — randomized controlled trial / PubMed
  • Nettle and metabolic or glycemic outcomes — systematic review and meta-analysis / PubMed
  • Nettle root preparations — evidence review / PubMed

Latest evidence

Recently published research

Searching Europe PMC…

Looking for recent publications…

These publications are automatically discovered from Europe PMC. They have not necessarily been independently reviewed by HerbParlor and are not automatically incorporated into the evidence assessment.

Evidence

Evidence

Human research on nettle is heterogeneous and preparation-dependent. Some studies report BPH/LUTS findings for specific root preparations and metabolic or glycemic findings for particular nettle interventions, but these findings do not establish nettle as a proven treatment for BPH, diabetes, inflammation or other diseases. Leaf/herb and root evidence must be kept separate, and evidence from one extract or study should not be generalized to every commercial product.

Evidence tier

Emerging

Confidence

Overall confidence is emerging rather than established. The main uncertainties concern plant part, preparation, extraction, amount, duration, study quality, population, outcome selection and whether a commercial product resembles the intervention studied. No dosage recommendation is made.

Last evidence review

2026-09-20

Where the evidence is strongest

Outcome-specific synthesis of BPH/LUTS and metabolic or glycemic researchPreparation-aware distinction between nettle leaf/herb and root

How to interpret this

Nettle evidence should be interpreted at the level of Urtica dioica identity, plant part, preparation, amount, outcome and study design. Some studies report BPH/LUTS and metabolic findings, but the evidence is heterogeneous and does not justify dosage recommendations or broad claims that nettle treats BPH, diabetes, inflammation or other diseases.

Automatic evidence update

Since the last editorial review

Checking Europe PMC…
Checking evidence

Checking for publications published since the last editorial evidence review…

This automatic update detects newly published literature; it does not replace HerbParlor's editorial evidence assessment. Review status is an automatic triage signal. Curated HerbParlor evidence is unchanged until editorial review.

Boundaries

What the evidence does NOT establish

Areas with limited evidence

  • Claims that nettle is an established treatment for BPH or diabetes
  • Broad anti-inflammatory or disease-treatment claims
  • Generalization of root evidence to leaf tea, leaf powder or leaf capsules
  • Generalization from one extract, glycerite or study to every nettle product

Evidence gaps

  • Larger, longer and well-described randomized trials with independent confirmation
  • Direct comparisons of leaf/herb and root preparations
  • Consistent reporting of plant part, preparation, extract characteristics and amount
  • Clinically meaningful outcomes and better assessment of long-term safety

Common misconceptions

  • Traditional use is not proof of efficacy.
  • Nettle root is not equivalent to nettle leaf or herb.
  • Root evidence for BPH/LUTS must not be generalized to leaf tea or leaf powder.
  • Some metabolic or glycemic findings do not establish nettle as a diabetes treatment.
  • A study of one extract or glycerite does not validate every nettle product.
  • Laboratory or biomarker findings are not automatically patient-important clinical benefit.

Safety

Safety & interactions

General considerations

  • Safety should be interpreted according to the specific nettle plant part, preparation, amount and duration studied; leaf/herb and root are not automatically equivalent.
  • Safety evidence is not equally established for every tea, powder, capsule, extract or glycerite product.
  • Product labels may not identify the plant part, extraction method or complete composition, which increases uncertainty.
  • Human research findings should not be treated as a complete safety profile for all commercial nettle products.

Pregnancy & nursing

  • Pregnancy and breastfeeding safety is not established for every nettle preparation, particularly concentrated extracts.
  • People who are pregnant or breastfeeding should discuss a specific product with a qualified healthcare professional.

Medication interactions to be aware of

Interaction information is incomplete across nettle plant parts and preparations. People taking medicines should discuss a specific product with a qualified healthcare professional rather than infer safety from traditional use.

Condition considerations

  • People with BPH or urinary symptoms should seek appropriate medical evaluation; this profile is not a substitute for diagnosis or treatment.
  • People with diabetes or other metabolic conditions should not use this profile to replace established care.
  • Uncertainty is greater when a product does not identify its species, plant part, preparation or amount.

Duration

  • Long-term safety of concentrated nettle extracts and glycerites is not equally established for every commercial product.

Talk to a healthcare professional if any apply

  • Pregnancy or breastfeeding
  • BPH, urinary symptoms or unexplained urinary changes
  • Diabetes or other metabolic conditions
  • Use of prescription medicines
  • Use of a concentrated extract or glycerite with unclear composition
  • Significant or unexpected adverse effects

Products

What changes between products?

Form differences

  • Leaf/herb and root are distinct plant parts and should not be treated as interchangeable preparations.
  • Root preparations used in BPH/LUTS research should not be generalized to leaf tea, leaf powder or leaf capsules.
  • Tea, powder, capsule, extract and glycerite products may differ in plant part, extraction method, composition and amount.
  • A named extract or research preparation is not automatically equivalent to every commercial nettle product.
  • Combination products should not automatically be treated as evidence for nettle alone.

Form considerations

  • Leaf/herb tea and powder are not automatically equivalent to root capsules or root extracts.
  • Tea, powder, capsule, extract and glycerite can represent different preparations and should not be compared solely by package size or headline amount.
  • A product listing a named extract should be assessed for whether the same preparation was used in the cited human research.

Plant part considerations

  • Confirm whether the product contains leaf/herb or root material.
  • Do not treat root evidence as evidence for leaf tea, leaf powder or other leaf products.
  • Do not infer plant part from the common name “nettle” alone.

Extract considerations

  • Record extract identity and extraction details only when the product source explicitly provides them.
  • Do not infer extraction ratios, concentration or clinical equivalence from an unspecified extract amount.

Standardization considerations

  • Record declared standardization only when genuinely disclosed and sourceable.
  • Do not invent marker-compound amounts or imply that standardization automatically means greater efficacy.

Evaluation

How to evaluate a supplement

What to check

  • Urtica dioica L. species identity where disclosed
  • Plant part: leaf/herb or root
  • Preparation: tea, powder, capsule, extract or glycerite
  • Whole plant material versus extract
  • Extraction information where explicitly disclosed
  • Amount and serving information only when genuinely disclosed
  • Whether the product is nettle alone or a combination formula
  • Other ingredients and label transparency
  • Identity, contaminant and batch or lot information where disclosed

Serving considerations

  • Compare the labelled preparation and amount with the intervention used in relevant research without turning that comparison into a dosage recommendation.
  • A larger declared amount does not automatically mean a stronger or better-supported product.

Testing considerations

  • Look for species and plant-part identity information where disclosed.
  • Look for contaminant testing and batch or lot traceability where disclosed.
  • Treat testing information as product-quality disclosure, not proof of clinical efficacy.

Label transparency

  • The species and plant part should be clear where possible.
  • Tea, powder, capsule, extract or glycerite preparation details should be explicit.
  • The labelled amount and serving should be explicit when disclosed.
  • Combination ingredients should be listed.
  • Marketing language should not be treated as human clinical evidence.

Supplements

Related supplements

Sources

Authoritative sources referenced

research-reviewedLast reviewed 2026-09-20Next review 2027-09-20

Sections reviewed

overviewbotanicaltraditionalContextpreparationsresearchevidencesafetyproductEvaluationrelationshipssources

Created the canonical Nettle Herb Profile v1 with Urtica dioica L. identity, leaf/herb and root distinction, preparation-aware BPH/LUTS and metabolic evidence, cautious safety framing, explicit evidence limits and product-evaluation criteria. No dosage recommendation is made.

Regulatory sources are included for context only. Regulatory status is not evidence for or against efficacy, and is not a treatment or safety recommendation.

This profile is provided for educational purposes only and is not medical advice. Traditional context and research summaries are distinguished from claims, and nothing here is a treatment recommendation. Always consult a qualified healthcare professional before using any herb, especially if you are pregnant, nursing, take medication, or have a medical condition.